Tech Company Financing Transactions

TearScience Funding Round

EW Healthcare Partners, De Novo Ventures and General Catalyst Partners participated in a $44.5 million Series C venture round for TearScience. The funding round was announced on 5/5/2010.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Medical Devices & Instruments

Mailing Address

5151 McCrimmon Pkwy. 250
Morrisville, NC 27560
USA

Phone

(919) 459-4880

Website

www.tearscience.com

Email Address

[email protected]

Overview

TearScience has pioneered diagnostic and treatment devices for evaporative dry eye, providing significant clinical improvement.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Joeseph Boorady

        

Chief Technical Officer

Donald Korb

        

VP - Marketing

Brian Regan

        

VP - R & D

Steve Grenon

        

VP - Regulatory Affairs

Christy Coleman

        

VP - Sales

Tom Chirillo

        

Browse more venture capital transactions:

Prev: 5/5/2010: Netronome venture capital transaction
Next: 5/5/2010: INVIDI Technologies venture capital transaction

Share this article

Where The Data Comes From

We do our best to document all VC transactions involving tech companies. VC transactions on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary